Related Experiment Video

Updated: Jun 30, 2025

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

589

Ruptured Mycotic Thoracic Aortic Aneurysm in the Setting of Streptococcus Bacteremia with Underlying Colonic

Jesse Chait1, Bernardo C Mendes1

  • 1Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.

Aorta (Stamford, Conn.)
|March 20, 2024
PubMed

Insights

A ruptured mycotic thoracic aortic aneurysm (TAA) in an 85-year-old female with Streptococcus bacteremia was successfully treated. The patient received a thoracic endograft and antibiotics for this complex condition.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Vascular Surgery

Background:

  • Mycotic thoracic aortic aneurysms (TAAs) present significant clinical challenges, particularly in elderly patients with comorbidities.
  • Ruptured TAAs are life-threatening emergencies requiring prompt and effective intervention.

Purpose of the Study:

  • To present a case of a successfully treated ruptured mycotic TAA with Streptococcus bacteremia.
  • To highlight the efficacy of thoracic endograft repair and antibiotic therapy in managing this complex condition.

Main Methods:

  • A case report of an 85-year-old female with a ruptured mycotic TAA and Streptococcus bacteremia.
  • Treatment involved emergent thoracic endograft placement and a course of antibiotics.

Main Results:

  • The patient with a ruptured mycotic TAA and bacteremia achieved a successful clinical outcome.
  • The thoracic endograft provided a durable repair, and antibiotic therapy eradicated the infection.

Conclusions:

  • Thoracic endograft repair is a viable and effective treatment option for ruptured mycotic TAAs.
  • Aggressive antibiotic management is crucial for treating the underlying infection in mycotic TAAs.

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

275
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.5K

Related Concept Videos

Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
61
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
93
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
181
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
325
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450